Table 3.
Outcomes at nine months after baseline.a
| Outcome | Intervention group (n=37) | Comparison group (n=61) | P valueb | |
| Deceased, n (%) | 1 (3) | 8 (13) | .15 | |
| Kidney transplant, n (%) | 1 (3) | 0 (0) | .80 | |
| Started dialysis, n (%) | 5 (14) | 5 (8) | .62 | |
| Location of dialysis start, n (%) |
|
|
.21 | |
|
|
Outpatient | 4 (80) | 1 (20) |
|
|
|
Inpatient | 1 (20) | 4 (80) |
|
|
|
Dialysis type, n (%) |
|
|
>.99 |
|
|
In-center hemodialysis | 3 (60) | 4 (80) |
|
|
|
Peritoneal dialysis | 2 (40) | 1 (20) |
|
|
|
Home hemodialysis | 0 (0) | 0 (0) |
|
| Last-recorded eGFRc before dialysis start, mean (SD) | 9.2 (4.0) | 8.4 (2.1) | .70 | |
| Days from baseline to dialysis start, median (range) | 183 (64-256) | 154 (14-258) | >.99 | |
| RASd inhibitors prescribed 6-9 months from baseline, n (%) | 20 (54) | 16 (26) | .01 | |
| Statin prescribed 6-9 months from baseline, n (%) | 26 (70) | 36 (59) | .28 | |
| Blood pressure control <140/<90, n (%) | 19 (51) | 30 (49) | >.99 | |
aPatients may be counted multiple times (eg, a patient who started dialysis and then died).
bFrom two-sample t tests for eGFR, Wilcoxon rank sum test for days to dialysis start, and chi-square tests for all other variables.
ceGFR: estimated glomerular filtration rate.
dRAS: renin-angiotensin system.